1. Home
  2. MLYS vs BLBD Comparison

MLYS vs BLBD Comparison

Compare MLYS & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$26.92

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$73.91

Market Cap

2.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
BLBD
Founded
2019
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
MLYS
BLBD
Price
$26.92
$73.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$48.67
$68.00
AVG Volume (30 Days)
916.3K
408.8K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
37.43
22.78
EPS
N/A
1.84
Revenue
N/A
$1,480,099,000.00
Revenue This Year
N/A
$5.87
Revenue Next Year
N/A
$6.83
P/E Ratio
N/A
$41.33
Revenue Growth
N/A
9.87
52 Week Low
$12.59
$42.95
52 Week High
$47.65
$83.39

Technical Indicators

Market Signals
Indicator
MLYS
BLBD
Relative Strength Index (RSI) 47.23 41.91
Support Level $26.01 $48.63
Resistance Level $31.26 $81.84
Average True Range (ATR) 1.21 2.82
MACD -0.13 -0.74
Stochastic Oscillator 18.55 25.04

Price Performance

Historical Comparison
MLYS
BLBD

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

Share on Social Networks: